The aim of this study was to further investigate the role of genes identified in our previous studies as relevant for the pathophysiology of Alzheimer’s disease and T2DM comorbidity, namely ATG16L1, ATG16L2, GABARAP, GABARAPL1, GABARAPL2, and SQSTM1. This evidence concerns the gene ATG16L2 and Alzheimer disease.